Defective Manufacturing Claims to Proceed Against Stryker in Trident Hip Case

NEW HAVEN, Conn. — Defective manufacturing claims brought against Stryker in connection with its Trident Hip Implant are not federally preempted because they are based on a violation of Food and Drug Administration requirements, a Connecticut federal judge has ruled.

However, in the March 31 order, Judge Janet C. Hall of the U.S. District Court for the District of Connecticut found the plaintiff’s claims of negligent design and failure to warn are preempted because they cast doubt on the FDA’s approval of the device’s design, instructions and warnings.

Denise Simoneau underwent a left total hip arthroplasty in December 2003, during …